Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 31-Jan-24 4:26 PM View:  | McDade Mark Director | Tourmaline Bio, Inc. (TRML) | 29-Jan-24 | Purchase | 100,000 | $32.50 | $3,250,000.00 | 16% 642.21K to 742.21K | |
| 20-Nov-23 10:00 PM View: | Kulkarni Sandeep Chidambar CEO Director | Tourmaline Bio, Inc. (TRML) | 17-Nov-23 | Purchase | 4,000 | $16.99 | $67,960.00 | < 1% 725.74K to 729.74K | |
| 20-Nov-23 10:00 PM View: | Thiara Parvinder Director | Tourmaline Bio, Inc. (TRML) | 17-Nov-23 | Purchase | 1,000 | $17.31 | $17,310.00 | 1% 82.78K to 83.78K | |
| 27-Oct-23 5:43 PM View: | Castelein Caley Director | Tourmaline Bio, Inc. (TRML) | 27-Oct-23 | Purchase | 15,800 | $14.55 | $229,890.00 | 2% 958.76K to 974.56K | |
| 26-Oct-23 5:34 PM View: | Kulkarni Sandeep Chidambar CEO Director | Tourmaline Bio, Inc. (TRML) | 26-Oct-23 | Purchase | 5,000 | $12.25 | $61,250.00 | < 1% 720.74K to 725.74K | |
| 26-Oct-23 4:46 PM View: | Thiara Parvinder Director | Tourmaline Bio, Inc. (TRML) | 25-Oct-23 | Purchase | 2,000 | $12.12 | $24,240.00 | 2% 80.78K to 82.78K | |
| 27-Oct-23 5:43 PM View: | Castelein Caley Director | Tourmaline Bio, Inc. (TRML) | 25-Oct-23 | Private Purchase | 4,200 | $12.07 | $50,694.00 | < 1% 954.56K to 958.76K | |
| 26-Oct-23 4:46 PM View: | Thiara Parvinder Director | Tourmaline Bio, Inc. (TRML) | 24-Oct-23 | Private Purchase | 5,000 | $10.66 | $53,300.00 | 7% 75.78K to 80.78K | |
| 26-Oct-23 5:34 PM View: | Kulkarni Sandeep Chidambar CEO Director | Tourmaline Bio, Inc. (TRML) | 24-Oct-23 | Private Purchase | 4,650 | $10.68 | $49,662.00 | < 1% 716.09K to 720.74K | |
| 26-Oct-23 5:00 PM View: | Kantoff Aaron Director | Tourmaline Bio, Inc. (TRML) | 24-Oct-23 | Private Purchase | 7,500 | $11.86 | $88,950.00 | 20% 37.89K to 45.39K | |
| 23-Oct-23 8:18 PM View: | Castelein Caley Director | Tourmaline Bio, Inc. (TRML) | 19-Oct-23 | Grant | 496,519 | -- | -- | 100% 0 to 496.52K | |
| 23-Oct-23 8:23 PM View: | Jones Susan Dana Chief Technology Officer | Tourmaline Bio, Inc. (TRML) | 19-Oct-23 | Grant | 22,934 | -- | -- | 100% 0 to 22.93K | |
| 23-Oct-23 8:25 PM View: | Kulkarni Sandeep Chidambar CEO Director | Tourmaline Bio, Inc. (TRML) | 19-Oct-23 | Grant | 716,085 | -- | -- | 100% 0 to 716.09K | |
| 23-Oct-23 8:26 PM View: | McDade Mark Director | Tourmaline Bio, Inc. (TRML) | 19-Oct-23 | Grant | 518 | -- | -- | < 1% 641.69K to 642.21K | |
| 23-Oct-23 8:18 PM View: | Castelein Caley Director | Tourmaline Bio, Inc. (TRML) | 19-Oct-23 | Grant | 458,039 | -- | -- | 92% 496.52K to 954.56K | |
| 23-Oct-23 8:20 PM View: | Chyung Yung H. Chief Medical Officer | Tourmaline Bio, Inc. (TRML) | 19-Oct-23 | Grant | 56,836 | -- | -- | 100% 0 to 56.84K | |
| 23-Oct-23 8:24 PM View: | Kantoff Aaron Director | Tourmaline Bio, Inc. (TRML) | 19-Oct-23 | Grant | 37,891 | -- | -- | 100% 0 to 37.89K | |
| 23-Oct-23 8:29 PM View: | Middlekauff W Bradford CBO, GC and Secretary | Tourmaline Bio, Inc. (TRML) | 19-Oct-23 | Grant | 69,201 | -- | -- | 100% 0 to 69.2K | |
| 23-Oct-23 8:31 PM View: | Srivastava Sapna Director | Tourmaline Bio, Inc. (TRML) | 19-Oct-23 | Grant | 518 | -- | -- | 100% 0 to 0.52K | |
| 23-Oct-23 8:21 PM View: | Johnson Kevin Bruce Chief Regulatory Officer | Tourmaline Bio, Inc. (TRML) | 19-Oct-23 | Grant | 57,834 | -- | -- | 100% 0 to 57.83K | |
| 23-Oct-23 8:26 PM View: | McDade Mark Director | Tourmaline Bio, Inc. (TRML) | 19-Oct-23 | Grant | 348,431 | -- | -- | 119% 293.26K to 641.69K | |
| 23-Oct-23 8:33 PM View: | Thiara Parvinder Director | Tourmaline Bio, Inc. (TRML) | 19-Oct-23 | Grant | 75,782 | -- | -- | 100% 0 to 75.78K | |
| 06-Jul-23 5:19 PM View: | Requadt Scott | Tourmaline Bio, Inc. (TRML) | 03-Jul-23 | Payment of Exercise | 11,786 | $3.08 | $36,300.90 | (1%) 1.04M to 1.03M | |
| 06-Jul-23 5:20 PM View: | Fenton Mary Kay Chief Financial Officer | Tourmaline Bio, Inc. (TRML) | 03-Jul-23 | Payment of Exercise | 12,946 | $3.08 | $39,873.70 | (16%) 81.0K to 68.05K | |
| 14-Jun-23 6:58 PM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 14-Jun-23 | Sale | 12,942 | $2.49 | $32,243.70 | (< 1%) 5.09M to 5.08M | |
| 14-Jun-23 6:58 PM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 13-Jun-23 | Sale | 14,208 | $2.56 | $36,338.40 | (< 1%) 5.11M to 5.09M | |
| 14-Jun-23 6:58 PM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 12-Jun-23 | Sale | 16,870 | $2.59 | $43,725.40 | (< 1%) 5.12M to 5.11M | |
| 09-Jun-23 5:41 PM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 09-Jun-23 | Sale | 25,419 | $2.46 | $62,637.50 | (< 1%) 5.15M to 5.12M | |
| 09-Jun-23 5:41 PM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 08-Jun-23 | Sale | 40,642 | $2.48 | $100,772.00 | (< 1%) 5.19M to 5.15M | |
| 09-Jun-23 5:41 PM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 07-Jun-23 | Sale | 75,001 | $2.39 | $179,095.00 | (1%) 5.26M to 5.19M | |
| 07-Jun-23 6:24 PM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 06-Jun-23 | Sale | 25,549 | $2.53 | $64,595.50 | (< 1%) 5.29M to 5.26M | |
| 07-Jun-23 6:24 PM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 05-Jun-23 | Sale | 7,841 | $2.52 | $19,754.60 | (< 1%) 5.3M to 5.29M | |
| 05-Jun-23 4:21 PM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 02-Jun-23 | Sale | 15,818 | $2.50 | $39,616.20 | (< 1%) 5.31M to 5.3M | |
| 05-Jun-23 4:21 PM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 01-Jun-23 | Sale | 15,713 | $2.56 | $40,176.60 | (< 1%) 5.33M to 5.31M | |
| 25-Apr-23 5:50 PM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 21-Apr-23 | Sale | 15,004 | $2.35 | $35,230.90 | (< 1%) 5.34M to 5.33M | |
| 21-Apr-23 7:57 AM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 20-Apr-23 | Sale | 46,990 | $2.33 | $109,313.00 | (< 1%) 5.39M to 5.34M | |
| 21-Apr-23 7:57 AM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 19-Apr-23 | Sale | 21,753 | $2.16 | $47,056.10 | (< 1%) 5.41M to 5.39M | |
| 19-Apr-23 9:22 AM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 18-Apr-23 | Sale | 49,211 | $2.15 | $105,804.00 | (< 1%) 5.46M to 5.41M | |
| 19-Apr-23 9:22 AM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 17-Apr-23 | Sale | 99,771 | $2.14 | $213,530.00 | (2%) 5.56M to 5.46M | |
| 20-Mar-23 4:36 PM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 17-Mar-23 | Sale | 10,436 | $2.06 | $21,543.00 | (< 1%) 5.57M to 5.56M | |
| 07-Mar-23 4:58 PM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 03-Mar-23 | Sale | 6,806 | $2.06 | $13,992.50 | (< 1%) 5.58M to 5.57M | |
| 02-Mar-23 5:26 PM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 01-Mar-23 | Sale | 29 | $2.05 | $59.45 | (< 1%) 5.58M to 5.58M | |
| 23-Feb-23 5:01 PM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 21-Feb-23 | Sale | 3,500 | $2.05 | $7,185.15 | (< 1%) 5.58M to 5.58M | |
| 21-Feb-23 11:16 AM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 17-Feb-23 | Sale | 3,612 | $2.05 | $7,405.68 | (< 1%) 5.59M to 5.58M | |
| 21-Feb-23 11:16 AM View: | Ildstad Suzanne Director | Tourmaline Bio, Inc. (TRML) | 16-Feb-23 | Sale | 2,939 | $2.06 | $6,039.94 | (< 1%) 5.59M to 5.59M | |
| 03-Feb-23 5:01 PM View: | Requadt Scott Chief Executive Officer Director | Tourmaline Bio, Inc. (TRML) | 30-Dec-22 | Grant | 4 | $0.87 | $3.47 | < 1% 1.04M to 1.04M | |
| 13-Sep-22 4:30 PM View: | Requadt Scott Chief Executive Officer Director | Tourmaline Bio, Inc. (TRML) | 10-Sep-22 | Grant | 80,000 | -- | -- | 8% 959.96K to 1.04M | |
| 13-Sep-22 4:29 PM View: | Fenton Mary Kay Chief Financial Officer | Tourmaline Bio, Inc. (TRML) | 10-Sep-22 | Grant | 80,000 | -- | -- | 8000% 1.0K to 81.0K | |
| 13-Sep-22 4:31 PM View: | Zdanowski Michael Chief Technology Officer | Tourmaline Bio, Inc. (TRML) | 10-Sep-22 | Grant | 120,000 | -- | -- | 8163% 1.47K to 121.47K | |
| 13-Sep-22 4:30 PM View: | Krieger Nancy Chief Medical Officer | Tourmaline Bio, Inc. (TRML) | 10-Sep-22 | Grant | 80,000 | -- | -- | 32% 250.23K to 330.23K |
